Yiu, Z Z N, Sorbe, C, Lunt, M, Rustenbach, S J, Kuehl, L, Augustin, M, Mason, K J, Ashcroft, D M, Griffiths, C E M, Warren, R B, Ormerod, A D, Barker, J N W N, Evans, L, McElhone, K, Smith, C H, Reynolds, N J, Murphy, R, Benham, M, Burden, A D, Hussain, S, Kirby, B, Lawson, L & Owen, C M 2019, ' Development and validation of a multivariable risk prediction model for serious infection in patients with psoriasis receiving systemic therapy ', British Journal of Dermatology, vol. 180, no. 4, pp. 894-901 . https://doi.org/10.1111/bjd.17421
Yiu, Z Z N, Ashcroft, D M, Evans, I, McElhone, K, Lunt, M, Smith, C H, Walton, S, Murphy, R, Reynolds, N J, Ormerod, A D, Griffiths, C E M, Warren, R B, Irshad, S, Wilde, V, Tahir, S, Ali, H, Mason, K, Hussain, S, Granger, E, Chalmers, R, Flohr, C, Watson, K, Prieto-Merino, D, Barker, J, Benham, M, Burden, D, Griffiths, C, Kirby, B, Lawson, L, Ormerod, A, Owen, C, Reynolds, N, Smith, C H & Warren, R 2019, ' Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the UK and Republic of Ireland: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR) ', British Journal of Dermatology, vol. 180, no. 2, pp. 329-337 . https://doi.org/10.1111/bjd.17036